The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biological Product Manufacturing-Global Market Insights and Sales Trends 2024
Synopsis
The biological product manufacturing is a complex process which produces products derived from recombinant DNA technology to develop a series of processes to manufacture therapeutic products. A biological product can be a virus, antitoxin, vaccine, blood component or derivative, allergenic product, or analogous product, or any therapeutic serum used for the treatment of a disease in humans. These biological products were developed from multicellular systems comprising of plants, animals, unicellular organisms and a mammalian cell. Biological products are composed of sugars, nucleic acids or combination of both.
The global Biological Product Manufacturing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biological Product Manufacturing in various end use industries. The expanding demands from the Hospitals, Specialized Clinics and Government Research Institutes,, are propelling Biological Product Manufacturing market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant Proteins segment is estimated at % CAGR for the next seven-year period.
The biological products are produced in three ways: by developing ways to achieve commercial production of the substance to be used, by gene alteration of the molecule and finally by developing an entirely new substance. Some of the tools used by modern day researcher in the manufacturing of biological products are recombinant DNA and monoclonal antibodies. Recombinant DNA involves altering of the DNA chain of one organism with desired DNA molecule to produce a novel biological product. Monoclonal antibodies were developed from single cell cultures using cloning techniques; these were designed to fight against toxins, viruses, and cancer cells. The first genetically engineered biological product approved for use in the U.S. was a vaccine for hepatitis-B which was approved in 1986, in the same year, other biological products like therapeutic monoclonal antibodies (MAB’s) and alpha interferon’s were approved.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biological Product Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biological Product Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biological Product Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biological Product Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biological Product Manufacturing covered in this report include Novartis, F.Hoffmann-La Roche, Merck, Bayer, Lonza, China Biologic Products, Pfizer, Sanofi and Teva Pharmaceutical Industries, etc.
The global Biological Product Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
F.Hoffmann-La Roche
Merck
Bayer
Lonza
China Biologic Products
Pfizer
Sanofi
Teva Pharmaceutical Industries
Amgen
Global Biological Product Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biological Product Manufacturing market, Segment by Type:
Monoclonal Antibodies
Recombinant Proteins
Growth Hormones
Beta Interferon
Therapeutic Enzymes
Global Biological Product Manufacturing market, by Application
Hospitals
Specialized Clinics
Government Research Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biological Product Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The biological product manufacturing is a complex process which produces products derived from recombinant DNA technology to develop a series of processes to manufacture therapeutic products. A biological product can be a virus, antitoxin, vaccine, blood component or derivative, allergenic product, or analogous product, or any therapeutic serum used for the treatment of a disease in humans. These biological products were developed from multicellular systems comprising of plants, animals, unicellular organisms and a mammalian cell. Biological products are composed of sugars, nucleic acids or combination of both.
The global Biological Product Manufacturing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biological Product Manufacturing in various end use industries. The expanding demands from the Hospitals, Specialized Clinics and Government Research Institutes,, are propelling Biological Product Manufacturing market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant Proteins segment is estimated at % CAGR for the next seven-year period.
The biological products are produced in three ways: by developing ways to achieve commercial production of the substance to be used, by gene alteration of the molecule and finally by developing an entirely new substance. Some of the tools used by modern day researcher in the manufacturing of biological products are recombinant DNA and monoclonal antibodies. Recombinant DNA involves altering of the DNA chain of one organism with desired DNA molecule to produce a novel biological product. Monoclonal antibodies were developed from single cell cultures using cloning techniques; these were designed to fight against toxins, viruses, and cancer cells. The first genetically engineered biological product approved for use in the U.S. was a vaccine for hepatitis-B which was approved in 1986, in the same year, other biological products like therapeutic monoclonal antibodies (MAB’s) and alpha interferon’s were approved.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biological Product Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biological Product Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biological Product Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biological Product Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biological Product Manufacturing covered in this report include Novartis, F.Hoffmann-La Roche, Merck, Bayer, Lonza, China Biologic Products, Pfizer, Sanofi and Teva Pharmaceutical Industries, etc.
The global Biological Product Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
F.Hoffmann-La Roche
Merck
Bayer
Lonza
China Biologic Products
Pfizer
Sanofi
Teva Pharmaceutical Industries
Amgen
Global Biological Product Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biological Product Manufacturing market, Segment by Type:
Monoclonal Antibodies
Recombinant Proteins
Growth Hormones
Beta Interferon
Therapeutic Enzymes
Global Biological Product Manufacturing market, by Application
Hospitals
Specialized Clinics
Government Research Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biological Product Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Biological Product Manufacturing
1.1 Biological Product Manufacturing Market Overview
1.1.1 Biological Product Manufacturing Product Scope
1.1.2 Biological Product Manufacturing Market Status and Outlook
1.2 Global Biological Product Manufacturing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Biological Product Manufacturing Market Size by Region (2018-2029)
1.4 Global Biological Product Manufacturing Historic Market Size by Region (2018-2023)
1.5 Global Biological Product Manufacturing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Biological Product Manufacturing Market Size (2018-2029)
1.6.1 North America Biological Product Manufacturing Market Size (2018-2029)
1.6.2 Europe Biological Product Manufacturing Market Size (2018-2029)
1.6.3 Asia-Pacific Biological Product Manufacturing Market Size (2018-2029)
1.6.4 Latin America Biological Product Manufacturing Market Size (2018-2029)
1.6.5 Middle East & Africa Biological Product Manufacturing Market Size (2018-2029)
2 Biological Product Manufacturing Market by Type
2.1 Introduction
2.1.1 Monoclonal Antibodies
2.1.2 Recombinant Proteins
2.1.3 Growth Hormones
2.1.4 Beta Interferon
2.1.5 Therapeutic Enzymes
2.2 Global Biological Product Manufacturing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Biological Product Manufacturing Historic Market Size by Type (2018-2023)
2.2.2 Global Biological Product Manufacturing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Biological Product Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Biological Product Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Biological Product Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Biological Product Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Biological Product Manufacturing Revenue Breakdown by Type (2018-2029)
3 Biological Product Manufacturing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Specialized Clinics
3.1.3 Government Research Institutes
3.2 Global Biological Product Manufacturing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Biological Product Manufacturing Historic Market Size by Application (2018-2023)
3.2.2 Global Biological Product Manufacturing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Biological Product Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Biological Product Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Biological Product Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Biological Product Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Biological Product Manufacturing Revenue Breakdown by Application (2018-2029)
4 Biological Product Manufacturing Competition Analysis by Players
4.1 Global Biological Product Manufacturing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biological Product Manufacturing as of 2022)
4.3 Date of Key Players Enter into Biological Product Manufacturing Market
4.4 Global Top Players Biological Product Manufacturing Headquarters and Area Served
4.5 Key Players Biological Product Manufacturing Product Solution and Service
4.6 Competitive Status
4.6.1 Biological Product Manufacturing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis Biological Product Manufacturing Products, Services and Solutions
5.1.4 Novartis Biological Product Manufacturing Revenue (US$ Million) & (2018-2023)
5.1.5 Novartis Recent Developments
5.2 F.Hoffmann-La Roche
5.2.1 F.Hoffmann-La Roche Profile
5.2.2 F.Hoffmann-La Roche Main Business
5.2.3 F.Hoffmann-La Roche Biological Product Manufacturing Products, Services and Solutions
5.2.4 F.Hoffmann-La Roche Biological Product Manufacturing Revenue (US$ Million) & (2018-2023)
5.2.5 F.Hoffmann-La Roche Recent Developments
5.3 Merck
5.3.1 Merck Profile
5.3.2 Merck Main Business
5.3.3 Merck Biological Product Manufacturing Products, Services and Solutions
5.3.4 Merck Biological Product Manufacturing Revenue (US$ Million) & (2018-2023)
5.3.5 Bayer Recent Developments
5.4 Bayer
5.4.1 Bayer Profile
5.4.2 Bayer Main Business
5.4.3 Bayer Biological Product Manufacturing Products, Services and Solutions
5.4.4 Bayer Biological Product Manufacturing Revenue (US$ Million) & (2018-2023)
5.4.5 Bayer Recent Developments
5.5 Lonza
5.5.1 Lonza Profile
5.5.2 Lonza Main Business
5.5.3 Lonza Biological Product Manufacturing Products, Services and Solutions
5.5.4 Lonza Biological Product Manufacturing Revenue (US$ Million) & (2018-2023)
5.5.5 Lonza Recent Developments
5.6 China Biologic Products
5.6.1 China Biologic Products Profile
5.6.2 China Biologic Products Main Business
5.6.3 China Biologic Products Biological Product Manufacturing Products, Services and Solutions
5.6.4 China Biologic Products Biological Product Manufacturing Revenue (US$ Million) & (2018-2023)
5.6.5 China Biologic Products Recent Developments
5.7 Pfizer
5.7.1 Pfizer Profile
5.7.2 Pfizer Main Business
5.7.3 Pfizer Biological Product Manufacturing Products, Services and Solutions
5.7.4 Pfizer Biological Product Manufacturing Revenue (US$ Million) & (2018-2023)
5.7.5 Pfizer Recent Developments
5.8 Sanofi
5.8.1 Sanofi Profile
5.8.2 Sanofi Main Business
5.8.3 Sanofi Biological Product Manufacturing Products, Services and Solutions
5.8.4 Sanofi Biological Product Manufacturing Revenue (US$ Million) & (2018-2023)
5.8.5 Sanofi Recent Developments
5.9 Teva Pharmaceutical Industries
5.9.1 Teva Pharmaceutical Industries Profile
5.9.2 Teva Pharmaceutical Industries Main Business
5.9.3 Teva Pharmaceutical Industries Biological Product Manufacturing Products, Services and Solutions
5.9.4 Teva Pharmaceutical Industries Biological Product Manufacturing Revenue (US$ Million) & (2018-2023)
5.9.5 Teva Pharmaceutical Industries Recent Developments
5.10 Amgen
5.10.1 Amgen Profile
5.10.2 Amgen Main Business
5.10.3 Amgen Biological Product Manufacturing Products, Services and Solutions
5.10.4 Amgen Biological Product Manufacturing Revenue (US$ Million) & (2018-2023)
5.10.5 Amgen Recent Developments
6 North America
6.1 North America Biological Product Manufacturing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Biological Product Manufacturing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biological Product Manufacturing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biological Product Manufacturing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biological Product Manufacturing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biological Product Manufacturing Market Dynamics
11.1 Biological Product Manufacturing Industry Trends
11.2 Biological Product Manufacturing Market Drivers
11.3 Biological Product Manufacturing Market Challenges
11.4 Biological Product Manufacturing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
